Published in Health and Medicine Week, April 4th, 2005
Goldberg will also support the company in its efforts to research and develop a pipeline of therapies for other diseases of aging.
Goldberg will implement key advocacy, business and public policy functions that support the company's AD therapeutic approach and anticipated pivotal studies. He brings more than 30 years experience to this new post, including...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.